| 摘要 |
PCT No. PCT/US95/05504 Sec. 371 Date Jan. 7, 1997 Sec. 102(e) Date Jan. 7, 1997 PCT Filed May 3, 1995 PCT Pub. No. WO95/29666 PCT Pub. Date Nov. 9, 1995The invention relates to a sustained-release pharmaceutical delivery system for the administration of an antioxidant drug to a patient in need of such drug, wherein said delivery system comprises said drug in combination with a polymeric matrix, said matrix comprising a polymer which does not interact with said drug or a mixture of such polymers. The pharmaceutical delivery system of the invention is useful for the treatment of pathological conditions involving pathologically increased formation of active oxygen species. |
